CDXS
Price
$1.33
Change
+$0.06 (+4.72%)
Updated
Feb 6 closing price
Capitalization
120.13M
17 days until earnings call
Intraday BUY SELL Signals
SANA
Price
$3.93
Change
+$0.38 (+10.70%)
Updated
Feb 6 closing price
Capitalization
1.05B
43 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CDXS vs SANA

Header iconCDXS vs SANA Comparison
Open Charts CDXS vs SANABanner chart's image
Codexis
Price$1.33
Change+$0.06 (+4.72%)
Volume$1.2M
Capitalization120.13M
Sana Biotechnology
Price$3.93
Change+$0.38 (+10.70%)
Volume$3.27M
Capitalization1.05B
CDXS vs SANA Comparison Chart in %
CDXS
Daily Signal:
Gain/Loss:
SANA
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
CDXS vs. SANA commentary
Feb 09, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CDXS is a Hold and SANA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 09, 2026
Stock price -- (CDXS: $1.33 vs. SANA: $3.93)
Brand notoriety: CDXS and SANA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CDXS: 112% vs. SANA: 91%
Market capitalization -- CDXS: $120.13M vs. SANA: $1.05B
CDXS [@Biotechnology] is valued at $120.13M. SANA’s [@Biotechnology] market capitalization is $1.05B. The market cap for tickers in the [@Biotechnology] industry ranges from $121.26B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CDXS’s FA Score shows that 1 FA rating(s) are green whileSANA’s FA Score has 0 green FA rating(s).

  • CDXS’s FA Score: 1 green, 4 red.
  • SANA’s FA Score: 0 green, 5 red.
According to our system of comparison, SANA is a better buy in the long-term than CDXS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CDXS’s TA Score shows that 4 TA indicator(s) are bullish while SANA’s TA Score has 5 bullish TA indicator(s).

  • CDXS’s TA Score: 4 bullish, 6 bearish.
  • SANA’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, SANA is a better buy in the short-term than CDXS.

Price Growth

CDXS (@Biotechnology) experienced а +7.26% price change this week, while SANA (@Biotechnology) price change was -11.29% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.30%. For the same industry, the average monthly price growth was -2.98%, and the average quarterly price growth was +31.79%.

Reported Earning Dates

CDXS is expected to report earnings on Feb 26, 2026.

SANA is expected to report earnings on Mar 24, 2026.

Industries' Descriptions

@Biotechnology (-2.30% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SANA($1.05B) has a higher market cap than CDXS($120M). SANA YTD gains are higher at: -3.440 vs. CDXS (-18.405). CDXS has higher annual earnings (EBITDA): -55.32M vs. SANA (-179.98M). SANA has more cash in the bank: 153M vs. CDXS (58.7M). CDXS has less debt than SANA: CDXS (68.6M) vs SANA (82.2M). CDXS has higher revenues than SANA: CDXS (52.9M) vs SANA (0).
CDXSSANACDXS / SANA
Capitalization120M1.05B11%
EBITDA-55.32M-179.98M31%
Gain YTD-18.405-3.440535%
P/E RatioN/AN/A-
Revenue52.9M0-
Total Cash58.7M153M38%
Total Debt68.6M82.2M83%
FUNDAMENTALS RATINGS
CDXS: Fundamental Ratings
CDXS
OUTLOOK RATING
1..100
55
VALUATION
overvalued / fair valued / undervalued
1..100
50
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
90
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
90

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CDXSSANA
RSI
ODDS (%)
Bullish Trend 4 days ago
81%
Bullish Trend 4 days ago
87%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
84%
Bullish Trend 4 days ago
89%
Momentum
ODDS (%)
Bearish Trend 4 days ago
87%
Bearish Trend 4 days ago
89%
MACD
ODDS (%)
Bearish Trend 4 days ago
84%
Bearish Trend 4 days ago
88%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
84%
Bearish Trend 4 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
83%
Bearish Trend 4 days ago
89%
Advances
ODDS (%)
Bullish Trend 19 days ago
82%
Bullish Trend 19 days ago
78%
Declines
ODDS (%)
Bearish Trend 5 days ago
85%
Bearish Trend 5 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
81%
Bullish Trend 4 days ago
85%
Aroon
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
79%
View a ticker or compare two or three
Interact to see
Advertisement
CDXS
Daily Signal:
Gain/Loss:
SANA
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CFSIX18.780.50
+2.74%
Touchstone Sands Capital Select Growth Y
NBGAX56.771.37
+2.47%
Neuberger Genesis Adv
NIEYX18.020.42
+2.39%
BNY Mellon International Equity Y
LLGLX15.020.21
+1.42%
Longleaf Partners Global
VLEQX11.420.12
+1.06%
Villere Equity

CDXS and

Correlation & Price change

A.I.dvisor indicates that over the last year, CDXS has been closely correlated with ARTV. These tickers have moved in lockstep 70% of the time. This A.I.-generated data suggests there is a high statistical probability that if CDXS jumps, then ARTV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CDXS
1D Price
Change %
CDXS100%
+4.72%
ARTV - CDXS
70%
Closely correlated
+4.13%
LENZ - CDXS
68%
Closely correlated
+1.79%
MREO - CDXS
66%
Closely correlated
+13.20%
RZLT - CDXS
66%
Closely correlated
+6.85%
TPST - CDXS
66%
Loosely correlated
+7.62%
More